https://www.selleckchem.com/pr....oducts/linderalacton
RESULTS Completion rates for all items were at least 80% regardless of time point or trial population. However, in three of the five trials, completion rates for the side effect bother item were lower at baseline compared to adjacent and non-adjacent items. This difference was not observed at 3 months. Up to 9.4% of patients reported high levels of side effect bother at baseline. CONCLUSION Patients may enter trials already reporting some bother from side effects. This can make interpretation of results with respect to the invest
Like
Comment
Share
